Needham downgrades Biogen on slow growth of Alzheimer's drug
Investing.com - Needham downgraded Biogen Inc (NASDAQ:BIIB) on Monday, citing slower-than-expected growth for its Alzheimer's ...
The Globe and Mail4m
Stocks Mostly Higher on Positive Corporate News
IQVIA Holdings (IQV) is down more than -2% after Mizuho Securities cut its price target on the stock to $247 from $277. Biogen (BIIB) is down more than -1% after Needham downgraded the stock to hold ...
modernretina9m
The European Commission approves biosimilar referencing aflibercept by Samsung Bioepis
The European Commission (EC) has approved OPUVIZ 40 mg/mL solution for injection in a vial. OPUVIZ is a biosimilar ...